Semaphorin 4D levels in heart failure patients:: do we have a novel biomarker of heart failure besides BNP?

Semaphorin 4D levels in heart failure patients: do we have a novel biomarker of heart failure besides BNP?

Nadav Asher Willner, Y. Goldberg, E. Schiff, Z. Vadasz

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	300-300
Journal	European Journal of Heart Failure
Volume	19
State	Published - May 2017

@article{4f68cfcbd1c04cc5b71a0877db6ec07c,

title = "Semaphorin 4D levels in heart failure patients:: do we have a novel biomarker of heart failure besides BNP?",

author = "Willner, {Nadav Asher} and Y. Goldberg and E. Schiff and Z. Vadasz",

year = "2017",

month = may,

language = "الإنجليزيّة",

volume = "19",

pages = "300--300",

journal = "European Journal of Heart Failure",

issn = "1388-9842",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Semaphorin 4D levels in heart failure patients:

T2 - do we have a novel biomarker of heart failure besides BNP?

AU - Willner, Nadav Asher

AU - Goldberg, Y.

AU - Schiff, E.

AU - Vadasz, Z.

PY - 2017/5

Y1 - 2017/5

M3 - موجز برنامج المؤتمر

SN - 1388-9842

VL - 19

SP - 300

EP - 300

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

ER -